Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 153,208 | 132,089 | 157,900 | 138,651 | 147,660 |
| Cost of Goods | 47,542 | 41,320 | 49,118 | 44,422 | 45,570 |
| Gross Profit | 105,666 | 90,769 | 108,782 | 94,229 | 102,090 |
| Operating Expenses | 87,081 | 82,673 | 89,414 | 83,399 | 84,292 |
| Operating Income | 19,127 | 8,416 | 19,486 | 11,252 | 18,368 |
| Interest Expense | 4,068 | 4,326 | 5,306 | 6,177 | 7,494 |
| Other Income | 249 | 427 | -37 | -405 | -561 |
| Pre-tax Income | 15,308 | 4,517 | 14,143 | 4,670 | 10,313 |
| Income Tax | -20,897 | 571 | -3,175 | 664 | 1,041 |
| Net Income Continuous | 36,205 | 3,946 | 17,318 | 4,006 | 9,272 |
| Minority Interests | 2,764 | 833 | 2,563 | 851 | 1,813 |
| Net Income | $33,441 | $3,113 | $14,755 | $3,155 | $7,459 |
| EPS Basic Total Ops | 0.49 | 0.05 | 0.22 | 0.05 | 0.11 |
| EPS Basic Continuous Ops | 0.53 | 0.06 | 0.19 | 0.06 | 0.14 |
| EPS Diluted Total Ops | 0.47 | 0.04 | 0.21 | 0.05 | 0.11 |
| EPS Diluted Continuous Ops | 0.51 | 0.06 | 0.19 | 0.06 | 0.14 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.15 | 0.24 | 0.15 | 0.21 |
| EBITDA(a) | $30,072 | $19,621 | $31,180 | $22,655 | $30,417 |